MerLion announces FDA approval of finafloxacin to treat otic ear infections

BC Venture, a fund managed by BC Brandenburg Capital GmbH, a subsidiary of Investitionsbank des Landes Brandenburg, announces FDA approval of finafloxacin for MerLion Pharmaceuticals.


Ansprechpartner


Petra Quehl Project Coordinator